NDC 0615-8504
Bupropion Hydrochloride 150 mg tablet, extended release
On the label: NCS HealthCare of KY, Inc dba Vangard Labs. It's repackaged: NCS HealthCare of KY, Inc dba Vangard Labs rebottles it from Rising Pharma Holdings, Inc.'s NDC 16571-862.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Graviti Pharmaceuticals Private Limited | Sangareddy, India | Makes it and tests it | Problems found, fixed voluntarilyJul 28, 2026 · 2 inspections |
Repackaging site
- NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY, United States · repackages it
Recalls
- Dec 29, 2023 · Class II · Rising Pharma Holding, Inc.
Presence of Foreign Tablets/Capsules
Lots: Lot #: BPA123098A, Exp. Date 06/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupropion: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 150 mg
- Approval
- ANDA ANDA211020
- On the market since
- Aug 1, 2022
- Package NDCs
0615-8504-050615-8504-39- Official label
- DailyMed (National Library of Medicine), updated Aug 12, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?